Related Experiment Video
Updated: May 22, 2025
Author Spotlight: Optimizing iPSC Differentiation for Efficient Production to Generate Kidney Organoids
Published on: September 1, 2023
Progress of Induced Pluripotent Stem Cell-Derived Renal Organoids in Clinical Application
Na Ning1,2,3, Zhiting Liu1,3, Xinyu Li1
1Department of Minimally Invasive Comprehensive Treatment of Cancer, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
Background:
Kidney disease has become a growing public health problem worldwide, and there is an urgent need to develop reliable models for investigating novel and effective treatment strategies. In recent years, kidney organoids, as novel models different from traditional two-dimensional cells and model animals, have attracted more and more attention. Current advances have allowed the generation of kidney organoids from the directed differentiation of induced pluripotent stem cells (iPSCs), which possess similar characteristics to embryonic stem cells, but bypass ethical constraints and have a wide range of sources.
Summary:
Herein, the methods of generating renal organoids from iPSCs, the applications of iPSC-derived renal organoids in disease modeling, drug effectiveness detection, and regenerative medicine as well as the challenges were reviewed.
Key Messages:
iPSC-derived renal organoids can be used to model kidney diseases and are great models for studying kidney injury and toxicity. Many efforts are needed to finally apply organoids into clinical application.
Insights
Induced pluripotent stem cell-derived kidney organoids offer advanced models for studying kidney disease and drug toxicity. These novel organoids show promise for regenerative medicine, though clinical applications require further development.
Area of Science:
- Biomedical Engineering
- Stem Cell Biology
- Regenerative Medicine
Background:
- Kidney disease is a significant global health concern, necessitating innovative research models.
- Kidney organoids derived from induced pluripotent stem cells (iPSCs) are emerging as superior alternatives to traditional 2D cell cultures and animal models.
- iPSCs offer ethical advantages and abundant sourcing for generating kidney organoids.
Purpose of the Study:
- To review the methodologies for generating renal organoids from iPSCs.
- To explore the diverse applications of iPSC-derived renal organoids in disease modeling, drug testing, and regenerative medicine.
- To identify current challenges and future directions for renal organoid technology.
Main Methods:
- Directed differentiation of induced pluripotent stem cells (iPSCs) into kidney organoids.
- Review of existing literature on iPSC-derived renal organoid generation and applications.
- Analysis of the potential of organoids in disease modeling and drug screening.
Main Results:
- iPSC-derived renal organoids recapitulate key kidney structures and functions.
- These organoids serve as effective models for studying kidney diseases, injury, and toxicity.
- The review highlights the potential of organoids in advancing drug discovery and personalized medicine.
Conclusions:
- iPSC-derived kidney organoids represent a significant advancement in modeling renal pathologies.
- Their application in drug efficacy and toxicity testing offers a promising avenue for pharmaceutical research.
- Further research and development are crucial for the clinical translation of kidney organoid technology.
